Agomab Therapeutics raised €41M in a Series B round in Jul 2022. The company is based in Ghent, Belgium. Investors in the round: Pfizer, Sabadell Asabys, Walleye Capital. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €41M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
